Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

NCT00153998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Liver Metastases

Interventions

DRUG: Cetuximab
PROCEDURE: Liver resection
DRUG: Cetuximab and FOLFIRI
DRUG: Cetuximab and FOLFOX

Sponsor

Technische Universität Dresden